Mobile footer menu with Twitter link

Join us on social

Incomplete Cancer Treatment

October 9, 2018

Breast cancer is less common in black women, yet they are 40% more likely to die from the disease than white women. New research suggests one possible reason: black women are less likely to complete 10-year endocrine therapies that can halve the risk of recurrence. While black and white women were both likely to stop treatment early, black women were less consistent in their regime.

The reasons are complex and require further research—from the burdens of being a caregiver, to “having doctors not listen to you, having employers that don't care about you,” says Niasha Fray of Duke University.